Glucon (www.glucon.com), developer of a continuous, noninvasive, blood glucose monitoring technology for home and clinical use, announced today the appointment of Mr. Daniel Goldberger as the Company’s new CEO.
Glucon (www.glucon.com), developer of a continuous, noninvasive, blood glucose monitoring technology for home and clinical use, announced today the appointment of Mr. Daniel Goldberger as the Company’s new CEO.